08.08.2022 - NEW HAVEN, Conn., Aug. 08, 2022 (GLOBE NEWSWIRE) - BIOASIS TECHNOLOGIES INC. (TSXV:BTI; OTCQB:BIOAF), (the “Company” or “Bioasis”), a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on .
BiOasis: Fiscal Q1 Earnings Snapshot apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.